Longitudinal change in mammographic density among ER-positive breast cancer patients using tamoxifen

Tamoxifen-associated mammographic density (MD) reductions are linked to improved breast cancer survival. We evaluated MD at six time points to determine the timing of greatest reduction following tamoxifen initiation. We sampled 40 Kaiser Permanente Northwest ER-positive breast cancer patients from...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Epidemiol Biomarkers Prev
Autori principali: Nyante, Sarah J., Sherman, Mark E., Pfeiffer, Ruth M., Berrington de Gonzalez, Amy, Brinton, Louise A., Aiello Bowles, Erin J., Hoover, Robert N., Glass, Andrew, Gierach, Gretchen L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4713329/
https://ncbi.nlm.nih.gov/pubmed/26545407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-15-0412
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi